Comparative Pharmacology
Head-to-head clinical analysis: DYANAVEL XR 5 versus METHYLIN ER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DYANAVEL XR 5 versus METHYLIN ER.
DYANAVEL XR 5 vs METHYLIN ER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CNS stimulant; blocks reuptake of norepinephrine and dopamine into presynaptic neurons, increasing their synaptic concentrations.
Methylphenidate is a central nervous system stimulant that blocks the reuptake of dopamine and norepinephrine into presynaptic neurons, increasing their availability in the synaptic cleft.
20 mg orally once daily in the morning; may increase by 10 mg weekly based on response; maximum 60 mg/day.
20-60 mg orally once daily in the morning
None Documented
None Documented
Terminal elimination half-life for d-amphetamine is 10-13 hours; for l-amphetamine, 13-16 hours. Clinical context: Twice-daily dosing may be required for sustained effect.
Mean 3-6 hours in adults; longer in children (4-8 hours). Clinical context: steady-state reached within 2 days; dosing every 8-12 hours.
Renal: ~90% as unchanged amphetamine and metabolites. Fecal: minimal (<5%).
Renal (90% as metabolites, <1% unchanged). Biliary/fecal: <2%.
Category C
Category C
CNS Stimulant
CNS Stimulant